These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29708812)

  • 1. Investigational drugs for the treatment of endometriosis, an update on recent developments.
    Barra F; Scala C; Mais V; Guerriero S; Ferrero S
    Expert Opin Investig Drugs; 2018 May; 27(5):445-458. PubMed ID: 29708812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of early drug development for endometriosis.
    Leone Roberti Maggiore U; Ferrero S
    Expert Opin Investig Drugs; 2016; 25(2):227-47. PubMed ID: 26619754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive review of hormonal and biological therapies for endometriosis: latest developments.
    Barra F; Grandi G; Tantari M; Scala C; Facchinetti F; Ferrero S
    Expert Opin Biol Ther; 2019 Apr; 19(4):343-360. PubMed ID: 30763525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and Emerging Therapeutics for the Management of Endometriosis.
    Ferrero S; Barra F; Leone Roberti Maggiore U
    Drugs; 2018 Jul; 78(10):995-1012. PubMed ID: 29946962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and emerging treatment options for endometriosis.
    Ferrero S; Evangelisti G; Barra F
    Expert Opin Pharmacother; 2018 Jul; 19(10):1109-1125. PubMed ID: 29975553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in pharmacotherapy for treating endometriosis.
    Tafi E; Leone Roberti Maggiore U; Alessandri F; Bogliolo S; Gardella B; Vellone VG; Grillo F; Mastracci L; Ferrero S
    Expert Opin Pharmacother; 2015; 16(16):2465-83. PubMed ID: 26569155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elagolix sodium for the treatment of women with moderate to severe endometriosis-associated pain.
    Barra F; Scala C; Ferrero S
    Drugs Today (Barc); 2019 Apr; 55(4):237-246. PubMed ID: 31050692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of elagolix for the treatment of endometriosis.
    Melis GB; Neri M; Corda V; Malune ME; Piras B; Pirarba S; Guerriero S; Orrù M; D'Alterio MN; Angioni S; Paoletti AM
    Expert Opin Drug Metab Toxicol; 2016 May; 12(5):581-8. PubMed ID: 27021205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigational drugs for endometriosis.
    Chlouber RO; Olive DL; Pritts EA
    Expert Opin Investig Drugs; 2006 Apr; 15(4):399-407. PubMed ID: 16548789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research development of a new GnRH antagonist (Elagolix) for the treatment of endometriosis: a review of the literature.
    Alessandro P; Luigi N; Felice S; Maria PA; Benedetto MG; Stefano A
    Arch Gynecol Obstet; 2017 Apr; 295(4):827-832. PubMed ID: 28255765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging drugs for endometriosis.
    Fedele L; Berlanda N
    Expert Opin Emerg Drugs; 2004 May; 9(1):167-77. PubMed ID: 15155142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of elagolix in the treatment of endometriosis.
    Perricos A; Wenzl R
    Expert Opin Pharmacother; 2017 Sep; 18(13):1391-1397. PubMed ID: 28737050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elagolix, a novel, orally bioavailable GnRH antagonist under investigation for the treatment of endometriosis-related pain.
    Ezzati M; Carr BR
    Womens Health (Lond); 2015 Jan; 11(1):19-28. PubMed ID: 25581052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linzagolix: a new GnRH-antagonist under investigation for the treatment of endometriosis and uterine myomas.
    Dababou S; Garzon S; Laganà AS; Ferrero S; Evangelisti G; Noventa M; D'Alterio MN; Palomba S; Uccella S; Franchi M; Barra F
    Expert Opin Investig Drugs; 2021 Sep; 30(9):903-911. PubMed ID: 34278887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of phase II and III drugs for the treatment and management of endometriosis.
    Perrone U; Evangelisti G; Laganà AS; Bogliolo S; Ceccaroni M; Izzotti A; Gustavino C; Ferrero S; Barra F
    Expert Opin Emerg Drugs; 2023 Dec; 28(4):333-351. PubMed ID: 38099328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of endometriosis by aromatase inhibitors: efficacy and side effects].
    Racine AC; Legrand E; Lefebvre-Lacoeuille C; Hoppe E; Catala L; Sentilhes L; Descamps P
    Gynecol Obstet Fertil; 2010 May; 38(5):318-23. PubMed ID: 20430665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of pharmacotherapy in the treatment of endometriosis across the lifespan.
    Schwartz K; Llarena NC; Rehmer JM; Richards EG; Falcone T
    Expert Opin Pharmacother; 2020 Jun; 21(8):893-903. PubMed ID: 32164462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New trends for the medical treatment of endometriosis.
    Rocha AL; Reis FM; Petraglia F
    Expert Opin Investig Drugs; 2012 Jul; 21(7):905-19. PubMed ID: 22568855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elagolix for endometriosis: all that glitters is not gold.
    Vercellini P; Viganò P; Barbara G; Buggio L; Somigliana E;
    Hum Reprod; 2019 Feb; 34(2):193-199. PubMed ID: 30551159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of medical treatment of endometriosis.
    Martone S; Troìa L; Marcolongo P; Luisi S
    Minerva Obstet Gynecol; 2021 Jun; 73(3):304-316. PubMed ID: 34008385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.